Live Breaking News & Updates on Kidney Week 2023

Stay updated with breaking news from Kidney week 2023. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pegloticase Plus Methotrexate Shows Hypertension Benefit in Gout Patients, with Richard Johnson, MD

Richard Johnson, MD, discusses the results of a study from ASN Kidney Week 2023 detailing the effects of urate-lowering therapy on blood pressure among patients with gout. ....

United States , Richard Johnson , Brad Marder , Division Of Renal Diseases , University Of Colorado Richard Johnson , University Of Colorado , Drug Administration , American Society Of Nephrology Kidney Week , American Society , Nephrology Kidney Week , Renal Diseases , Biologics License Application , Kidney Week , Pressure Changes , Intensive Urate Lowering , Uncontrolled Gout Patients , Asn Kidney Week , Kidney Week 2023 , Pegloticase With Methotrexate ,

Repeat Biopsy Analysis Underlines Safety, Efficacy of Voclosporin in Lupus Nephritis

An analysis of data from 26 patients with repeat kidney biopsies in the AURORA program suggests voclosporin (Lupkynis) reduces proteinuria without causing harm in lupus nephritis patients. ....

United States , Samirv Parikh , Greg Keenan , American Society Of Nephrology Kidney Week , Drug Administration , Aurinia Pharmaceuticals Inc , Ohio State University Wexner Medical Center , American Society , Nephrology Kidney Week , Ohio State University Wexner Medical , Aurinia Pharmaceuticals , Aurinia Pharmaceutical , Lupus Nephritis , Kidney Week , Kidney Week 2023 ,

Phase 2b Data, Phase 3 Trial Design Provide New Insight into Atacicept in IgAN

Data from multiple presentations at ASN Kidney Week 2023 offer insight into the effects of atacicept in patients with IgA nephropathy as well as the design of the phase 3 trial, which is currently enrolling. ....

United States , Richard Lafayette , American Society Of Nephrology Kidney Week , Stanford Glomerular Disease Center , American Society , Nephrology Kidney Week , Kidney Week , Evaluating Effect , Renal Function Preservation , Iga Nephropathy , Paper Presented , Vera Therapeutics , Asn Kidney Week , Kidney Week 2023 ,

Combination Zibotentan/Dapagliflozin Reduces Albuminuria in CKD

Results of the ZENITH-CKD trial provide evidence of the safety and efficacy profile of combination zibotentan plus dapagliflozin in patients with chronic kidney disease. ....

United States , Sharon Barr , Hiddo Heerspink , Biopharmaceuticals Research , George Clinical Institute Hiddo Jl Heerspink , American Society Of Nephrology Kidney Week , University Medical Center Groningen , University Of Groningen , Department Of Clinical Pharmacy , George Clinical Institute , American Society , Nephrology Kidney Week , Clinical Pharmacy , University Medical Center , Standard Deviation , Confidence Interval , Combination Sglt2 , Asn Kidney Week , Kidney Week 2023 , Asn 2023 , Zenith Ckd ,

PROTECT: Sparsentan Outperforms Irbesartan in IgA Nephropathy

The 2-year data from the PROTECT study confirms the sustained benefit of sparsentan in patients with IgA nephropathy. ....

United States , Brad Rovin , Campbellp Sparsentan , Jula Inrig , National Institute Of Diabetes , Ohio State University Brad Rovin , American Society Of Nephrology , Kidney Function Decline On Health Care , Travere Therapeutics Inc , Ohio State University , American Society Of Nephrology Kidney Week , Division For Nephrology , Clinical Research Management , American Society , Nephrology Kidney Week , Ohio State , Kidney Week , Travere Therapeutics , Relative Risk , Accessed November , Kidney Function Decline , Health Care Costs , Resource Utilization , Adults With Iga Nephropathy , Filspari For Igan , Kidney Week 2023 ,